Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Plos One|April 19, 2018
Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in womenInês Bártolo, Ana Rita Diniz, Pedro Borrego, et al.
European Journal of Medicinal Chemistry|April 22, 2021
Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and PlasmodiumNuno Guerreiro Alves, Inês Bártolo, Américo J S Alves, et al.
Current Topics in Medicinal Chemistry|November 9, 2019
Spiro-Lactams as Novel Antimicrobial AgentsAmérico J S Alves, Nuno G Alves, Cátia C Caratão, et al.
International Journal of Molecular Sciences|November 26, 2022
High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing PatientsInês Bártolo, Inês Moranguinho, Paloma Gonçalves, et al.
International Journal of Molecular Sciences|July 9, 2022
Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) ComplexesYann Le Gal, Agathe Filatre-Furcate, Dominique Lorcy, et al.
Journal of the International AIDS Society|July 28, 2025
Impact of point-of-care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trialAnange Fred Lwilla, Kira Elsbernd, Siriel Boniface, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2024
Impact of Point-of-Care Birth Test-and-Treat on Clinical Outcomes Among Infants With HIV: A Cluster-Randomized Trial in Mozambique and TanzaniaIlesh V Jani, Issa Sabi, Kira Elsbernd, et al.
ACS Infectious Diseases|December 15, 2020
Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid ProteinIris Cadima-Couto, Alexandra Tauzin, João M Freire, et al.
AIDS (London, England)|April 9, 2016
Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitorsCatarina Cunha-Santos, Tiago N Figueira, Pedro Borrego, et al.
The Journal of General Virology|December 23, 2011
Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group ANuno R Faria, Ioannis Hodges-Mameletzis, Joana C Silva, et al.
Pageof 9